SHANGHAI, Jan. 18, 2026 /PRNewswire/ — D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, today announcedSHANGHAI, Jan. 18, 2026 /PRNewswire/ — D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, today announced

D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002

SHANGHAI, Jan. 18, 2026 /PRNewswire/ — D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared two Investigational New Drug (IND) applications:

  • D3S‑003 — a KRAS G12D inhibitor — enabling the start of a Phase 1 first‑in‑human clinical trial.
  • A Phase 2 combination trial evaluating D3S‑001 (elisrasib), the Company’s next‑generation KRAS G12C inhibitor, in combination with D3S‑002, a selective oral ERK1/2 inhibitor.

D3S‑003 is an orally bioavailable, allele‑specific KRAS G12D inhibitor that targets both the GDP‑bound (OFF) and GTP‑bound (ON) conformations. Preclinical data demonstrate a differentiated, best‑in‑class profile with potent anti‑tumor activity, favorable drug‑like characteristics, and a promising safety margin. With FDA clearance received, D3 Bio will advance D3S‑003 into a Phase 1 first‑in‑human study in patients with advanced solid tumors harboring KRAS G12D mutations.

The newly cleared Phase 2 study will evaluate the combination of D3S‑001 and D3S‑002 in patients with KRAS G12C–mutant non‑small cell lung cancer (NSCLC) who have progressed on prior KRAS G12C‑targeted therapies. The trial, expected to begin in the first half of 2026, will investigate safety, pharmacokinetics, and early efficacy signals with the goal of establishing a rational combination strategy to address resistance and deliver more durable benefit in KRAS‑driven cancers.

“We are excited to receive FDA IND clearance for D3S‑003 and to advance a Phase 2 combination clinical trial of elisrasib and D3S‑002,” said George Chen, Founder, Chairman and Chief Executive Officer of D3 Bio. “With D3S‑003, we are bringing a differentiated KRAS G12D inhibitor into the clinic to address one of the most prevalent and challenging KRAS mutations. In parallel, the combination study of elisrasib and D3S‑002 pushes forward our next‑generation KRAS G12C strategy, particularly for patients who have progressed on prior KRAS G12C‑targeted therapies. Together, these milestones underline the momentum of our KRAS franchise and reinforce our commitment to delivering transformative therapies for patients with KRAS‑mutant cancers who urgently need new options.”

About Elisrasib (D3S-001)

Elisrasib is a next‑generation KRAS G12C inhibitor designed for rapid, complete, and selective target engagement. It covalently binds the GDP‑bound (OFF) form of KRAS G12C, effectively blocking nucleotide cycling and suppressing oncogenic signaling. Preclinical studies show robust potency, complete KRAS G12C engagement at clinically relevant exposures, and CNS penetration capability. Elisrasib is currently being evaluated globally in a Phase 2 monotherapy and combination trial across KRAS G12C–mutant solid tumors including NSCLC, CRC, and others.

Key publications:

  • Cancer Discovery (2024) 14(9):1675–1698
  • Nature Medicine (2025) 31(8):2768–2777

About D3S‑002

D3S‑002 is a selective ERK1/2 inhibitor strategically designed for combination approaches, providing vertical MAPK‑pathway inhibition to enhance efficacy and overcome acquired resistance, particularly in tumors previously treated with KRAS G12C inhibitors.

Key publication:

  • Cancer Res 1 April 2023; 83 (7_Supplement): 5501.

About D3S‑003

D3S‑003 is a differentiated KRAS G12D inhibitor targeting both OFF and ON conformations to address one of the most common KRAS mutations. The program aims to broaden D3 Bio’s multi‑allele KRAS franchise and deliver new solutions for the heterogeneous and evolving landscape of KRAS‑driven cancers.

About D3 Bio

D3 Bio is a global biotechnology company focused on the discovery, development, and registration of novel oncology and immunology therapies with first‑ or best‑in‑class potential. Guided by deep clinical insight and biomarker‑driven strategies, the Company is advancing a pipeline of programs targeting key oncogenic drivers and immune pathways. D3 Bio owns global rights to all its programs.

For more information, please visit www.d3bio.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/d3-bio-receives-us-fda-clearance-for-two-ind-applications-enabling-phase-1-trial-of-d3s003-and-phase-2-combination-study-of-elisrasib-d3s001-with-d3s002-302664022.html

SOURCE D3 Bio

Market Opportunity
Ucan fix life in1day Logo
Ucan fix life in1day Price(1)
$0.001157
$0.001157$0.001157
-10.37%
USD
Ucan fix life in1day (1) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Crucial Fed Rate Cut: Powell’s Bold Risk Management Move Explained

Crucial Fed Rate Cut: Powell’s Bold Risk Management Move Explained

BitcoinWorld Crucial Fed Rate Cut: Powell’s Bold Risk Management Move Explained In a significant development for global financial markets, Federal Reserve Chair Jerome Powell recently described the latest Fed rate cut as a critical risk management measure. This statement immediately captured the attention of investors, economists, and especially those in the dynamic cryptocurrency space. Understanding Powell’s rationale and the potential implications of this move is essential for navigating today’s complex economic landscape. What Exactly is a Fed Rate Cut and Why Does it Matter? A Fed rate cut refers to the Federal Reserve lowering the target range for the federal funds rate. This is the interest rate at which commercial banks borrow and lend their excess reserves to each other overnight. When the Fed lowers this rate, it typically makes borrowing cheaper across the entire economy. This decision impacts everything from mortgage rates to business loans. The Fed uses interest rates as a primary tool to influence economic activity, aiming to achieve maximum employment and stable prices. A lower rate often stimulates spending and investment, but it can also signal concerns about economic slowdown. Key reasons for a rate cut often include: Slowing economic growth or recession fears. Low inflation or deflationary pressures. Global economic instability impacting domestic markets. A desire to provide more liquidity to the financial system. Powell’s emphasis on ‘risk management’ suggests a proactive approach. The Fed is not just reacting to current data but also anticipating potential future challenges. They are essentially trying to prevent a worse economic outcome by adjusting policy now. How Does a Fed Rate Cut Influence the Broader Economy? When the Federal Reserve implements a Fed rate cut, it sends ripples throughout the financial world. For traditional markets, lower interest rates generally mean: Boost for Stocks: Companies can borrow more cheaply, potentially increasing profits and stock valuations. Investors might also move money from lower-yielding bonds into equities. Cheaper Borrowing: Consumers and businesses enjoy lower rates on loans, from mortgages to credit cards, encouraging spending and investment. Weaker Dollar: Lower rates can make a country’s currency less attractive to foreign investors, potentially leading to a weaker dollar. Bond Market Shifts: Existing bonds with higher yields become more attractive, while newly issued bonds will have lower yields. This shift in monetary policy aims to inject confidence and liquidity into the system, countering potential economic headwinds. However, there’s always a delicate balance to strike, as too much stimulus can lead to inflationary pressures down the line. What Does This Fed Rate Cut Mean for Cryptocurrency Investors? The impact of a Fed rate cut on the cryptocurrency market is often a topic of intense discussion. While crypto assets operate independently of central banks, they are not immune to broader macroeconomic forces. Here’s how a rate cut can play out: Increased Risk Appetite: With traditional savings and bond yields potentially lower, investors might seek higher returns in riskier assets, including cryptocurrencies like Bitcoin and Ethereum. Inflation Hedge Narrative: Some view cryptocurrencies, particularly Bitcoin, as a hedge against inflation and traditional currency debasement. If a rate cut leads to concerns about inflation, this narrative could gain traction. Liquidity Influx: A more accommodative monetary policy can increase overall liquidity in the financial system, some of which may flow into digital assets. Dollar Weakness: A weaker dollar, a potential consequence of rate cuts, can sometimes make dollar-denominated assets like crypto more appealing to international investors. However, it’s crucial to remember that the crypto market also has its unique drivers, including technological developments, regulatory news, and market sentiment. While a Fed rate cut can provide a tailwind, it’s not the sole determinant of crypto performance. Navigating the New Landscape: Actionable Insights for Crypto Investors Given the Federal Reserve’s stance on risk management through a Fed rate cut, what steps can crypto investors consider? Stay Informed: Keep a close watch on further Fed announcements and economic data. Understanding the broader macroeconomic picture is vital. Diversify Your Portfolio: While a rate cut might favor risk assets, a balanced portfolio that includes a mix of traditional and digital assets can help mitigate volatility. Long-Term Perspective: Focus on the fundamental value and long-term potential of your chosen cryptocurrencies rather than short-term fluctuations driven by macro news. Assess Risk Tolerance: Re-evaluate your personal risk tolerance in light of potential market shifts. Lower rates can encourage speculation, but prudence remains key. Powell’s description of the Fed rate cut as a risk management measure highlights the central bank’s commitment to maintaining economic stability. For cryptocurrency enthusiasts, this move underscores the increasing interconnectedness of traditional finance and the digital asset world. While a rate cut can create opportunities, a thoughtful and informed approach is always the best strategy. Frequently Asked Questions (FAQs) What exactly is a Fed rate cut? A Fed rate cut is when the Federal Reserve lowers its target for the federal funds rate, which is the benchmark interest rate banks charge each other for overnight lending. This action makes borrowing cheaper across the economy, aiming to stimulate economic activity. Why did Powell emphasize “risk management” for this Fed rate cut? Jerome Powell emphasized “risk management” to indicate that the Fed was proactively addressing potential economic slowdowns or other future challenges. It suggests a preventative measure to safeguard against adverse economic conditions rather than merely reacting to existing problems. How does a Fed rate cut typically affect the crypto market? A Fed rate cut can make traditional investments less attractive due to lower yields, potentially driving investors towards higher-risk, higher-reward assets like cryptocurrencies. It can also increase overall market liquidity and strengthen the narrative of crypto as an inflation hedge. Should crypto investors change their strategy after a rate cut? While a rate cut can influence market dynamics, crypto investors should primarily focus on their long-term strategy, fundamental research, and risk tolerance. It’s wise to stay informed about macroeconomic trends but avoid making impulsive decisions based solely on a single policy change. What are the potential downsides of a Fed rate cut? Potential downsides include increased inflationary pressures if the economy overheats, a weaker national currency, and the possibility of creating asset bubbles as investors chase higher returns in riskier markets. It can also signal underlying concerns about economic health. Did you find this article insightful? Share your thoughts and help others understand the implications of the Fed’s latest move! Follow us on social media for more real-time updates and expert analysis. To learn more about the latest crypto market trends, explore our article on key developments shaping Bitcoin’s price action. This post Crucial Fed Rate Cut: Powell’s Bold Risk Management Move Explained first appeared on BitcoinWorld.
Share
Coinstats2025/09/18 16:40
Why Vitalik Buterin Just Pulled 16,384 ETH From His Holdings

Why Vitalik Buterin Just Pulled 16,384 ETH From His Holdings

The post Why Vitalik Buterin Just Pulled 16,384 ETH From His Holdings appeared first on Coinpedia Fintech News Ethereum co-founder Vitalik Buterin just withdrew
Share
CoinPedia2026/01/30 18:19
Record-breaking streak ends – Rabobank

Record-breaking streak ends – Rabobank

The post Record-breaking streak ends – Rabobank appeared on BitcoinEthereumNews.com. Rabobank’s report notes that Gold has seen a significant retracement, ending
Share
BitcoinEthereumNews2026/01/30 18:24